CGIM
KRTX

Capital Group Investment Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Capital Group Investment Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,776
Closed -$1.2M – 198
2023
Q4 		$1.2M Buy
3,776
+1,494
+65% +$290K 0.13% 137
2023
Q3 		$386K Hold
2,282
– – 0.03% 183
2023
Q2 		$495K Buy
+2,282
New +$489K 0.02% 178

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Capital Group Investment Management's KRTX Position: Q1 2024 in Review

Capital Group Investment Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 3,776 shares — an estimated $1.2M sold.

Capital Group Investment Management first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $1.2M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Capital Group Investment Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Capital Group Investment Management sold 3,776 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.2M.
  • Capital Group Investment Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Capital Group Investment Management's Karuna Therapeutics, Inc. Common Stock position peaked at $1.2M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Capital Group Investment Management's 13F filing for Q1 2024, filed 14 May 2024.